Introduction
Dopamine and its receptors are involved in the regulation of mood, motivation and motor function in the mature central nervous system (CNS). However, dopamine is present in the brain early in development and functional dopamine receptors are expressed in the CNS prior to the onset of synaptogenesis [Jung and Bennett, 1996; Diaz et al., 1997; Shearman et al., 1997; Ohtani et al., 2003] , suggesting a role for dopamine in brain development that may be independent of its role at the synapse in the mature CNS [Lauder, 1988 [Lauder, , 1993 Levitt et al., 1997; Nguyen et al., 2001; Ohtani et al., 2003] . Neurotransmitters such as dopamine can infl uence brain development by modulating neurogenesis or neuronal and glial cell differentiation [LoTurco et al., 1995; Schmidt et al., 1996; Lavdas et al., 1997; Bongarzone et al., 1998; Haydar et al., 2000; Popovik and Haynes, 2000; Demarque et al., 2002; Luk et al., 2003; Luk and Sadikot, 2004; Popolo et al., 2004] . Recent studies show that dopamine receptor activation infl uences the cell cycle of neuroepithelial cells in the lateral ganglionic eminence and the cerebral wall [Zhang and Lidow, 2002; Ohtani et al., 2003; Popolo et al., 2004; Zhang et al., 2005] . Activation of dopamine D 1 receptor (D1R) decreases incorporation of the S-phase marker bromodeoxyuridine (BrdU) by neuroepithelial cells whereas activation of the D 2 receptor (D2R) increases it [Ohtani et al., 2003; Popolo et Dopamine Receptor Cell Lines Dev Neurosci 2006; 28:518-527 519 al., 2004] . The molecular mechanisms mediating the effects of dopamine receptor activation on cell proliferation or differentiation are only now beginning to be understood [Zhang and Lidow, 2002; Zhang et al., 2005] .
Availability of precursor cell lines expressing D1R and D2R could facilitate investigation of the cell and molecular mechanisms of dopamine's action on precursor cells, neurons and glia in the developing brain. We characterized D1R and D2R expression and activity in a mouse striatal precursor cell line ST Hdh + / Hdh + [Trettel et al., 2000] that was established by retroviral transduction of the temperature-sensitive mutant tsA58 of the SV40 large T antigen so that the cells remain proliferative at 33 ° C and lose the SV40 tsA58 oncoprotein and cease proliferation at 39 ° C [Cattaneo and Conti, 1998; Trettel et al., 2000] . We found that the ST Hdh + / Hdh + cell line expressed predominantly D2R mRNA and only low levels of D1R mRNA. Therefore, we stably transfected the ST Hdh + / Hdh + cell line with mouse D1R constructs to generate a new cell line that would express functional D1R in addition to the endogenous D2R. We examined the effects of activation of D1R and D2R on cell proliferation and differentiation in these cell lines and our data show that the cell lines can be useful in vitro tools to examine the effects of dopamine receptor activation on the activity of striatal progenitor cells.
Materials and Methods

Generation of Cell Lines Expressing Mouse D1R-EGFP or EGFP Transgenes
Our initial experiments showed that the ST Hdh + / Hdh + cell line expressed D2R mRNA and only low levels of D1R mRNA (see below). Therefore, we stably transfected the ST Hdh + / Hdh + line with a mouse D1R-EGFP construct or an EGFP reporter construct to generate two new cell lines, as follows.
Plasmids. We cloned mouse dopamine receptor cDNA from Mouse Brain QUICK-Clone cDNA (BD Biosciences/Clontech, San Jose, Calif., USA) by PCR using the following primers: 5 -CGCTCGAGCGCCACCGAAGATGGCTCCTAACACTT-3 and 5 -CGGGATCCGGTTGAATGCTGCTGTCCGCTGT-3 . The primers were designed to eliminate the stop codon. EGFPtagged D1R construct (pD1R-EGFP) was designed by in-frame cloning of Xho I and Bam HI fragment DNA from PCR products into pEGFP-N3 vector (BD Biosciences/Clontech) ( fi g. 1 ).
Stable Transfection. ST Hdh + / Hdh + cells remain proliferative at 33 ° C and cease proliferation at 39 ° C [Trettel et al., 2000] . We transfected ST Hdh + / Hdh + cells growing at 33 ° C with either pD1R-EGFP or pEGFP-N3 and pPUR ( fi g. 1 a) (BD Biosciences/Clontech) using LipofectAMINE™ 2000 (Invitrogen, Rockville, Md., USA), according to the manufacturer's instructions. Transfected colonies were selected by growing in medium containing 0.8 mg/ml Geneticin, and 40 g/ml puromycin (Invitrogen) followed by cell sorting (FACSVantage™; BD Biosciences, Franklin Lakes, N.J., USA). Stable transfection was also confi rmed by observing EGFP expression in the cells or colonies under a fl uorescence microscope. Thus, we generated two new cell lines: the D1R-EGFP line expressing wild-type mouse D1R-EGFP and the EGFP line expressing only the EGFP reporter sequence. We used these two lines along with the original ST Hdh + / Hdh + line in the experiments described here.
Cell Culture
Cells were grown at 33 ° C in Dulbecco's modifi ed Eagle's medium supplemented with 10% fetal bovine serum, 1% nonessential amino acids, 2 m M L -glutamine, 1% penicillin-streptomycin, 0.8 mg/ml Geneticin, and 40 g/ml puromycin (Invitrogen). The cells remain proliferative under these conditions [Cattaneo and Conti, 1998; Trettel et al., 2000] . In other experiments involving cell differentiation, the cells were cultured at 37 ° C in 8-well culture chambers (BD Biosciences) at a density of 1 ! 10 4 cells per well in a differentiation medium [Neurobasal/B27, 2 m M L -glutamine, 1% penicillin-streptomycin (Invitrogen), and 0.5% D -glucose (Sigma, St. Louis, Mo., USA)]. The medium was changed every other day. For immunoblot analysis, 5 ! 10 5 cells were cultured in a 100-mm cell culture dish (BD Biosciences).
Application of Drugs
Dopamine (10 M ), D1R agonist SKF81297 (1 M ), D1R antagonist Schering 23390 (10, 20 M ), D2R agonist quinpirole (10 M ) or forskolin (25, 50 M ) (all chemicals from Sigma-RBI) were added to the culture medium directly. D1R antagonist was applied 30 min prior to agonist application in experiments designed to test specifi city of D1R activation. For analysis of cell proliferation, BrdU (10 m M ; Sigma) was added to the medium 1 h prior to fi xation.
RT-PCR for D1R and D2R
We isolated total RNA from cells by using RNAqueous-4PCR (Ambion, Austin, Tex., USA) and reverse transcribed 2 g of total RNA to synthesize cDNA. The following primer sets were used: for D1R: 5 -AGCAGGACGTATGCCATTTC-3 , 5 -CCACACAAA-CACATCGAAGG-3 ; for D1R-EGFP: 5 -AAGGCATTCTC-GACCCTCTT-3 , 5 -TGGTGCAGATGAACTTCAGG-3 ; for EGFP: 5 -ACGTAAACGGCCACAAGTTC-3 , 5 -TGTTCTGC-TGGTAGTGGTCG-3 ; for D2R: 5 -ACCACGGCCTACATAG-CAAC-3 , 5 -GTGAAGGCGCTGTAGAGGAC-3 , and for actin: 5 -CACGGCATTGTAACCAACTG-3 , 5 -TCTCAGCTGTGG-TGGTGAAG-3 .
Cyclic Adenosine Monophosphate Assay
We examined cyclic adenosine monophosphate (cAMP) accumulation following activation of the dopamine receptors in the different cell lines. For these experiments, we cultured 4 ! 10 4 cells in 24-well plates for 2 days at 37 ° C in Dulbecco's modifi ed Eagle's medium supplemented with 10% fetal bovine serum, 1% nonessential amino acids, 2 m M L -glutamine, 1% penicillin-streptomycin, 0.8 mg/ml Geneticin, and 40 g/ml puromycin (Invitrogen).
Then, the cells were washed with PBS twice and dopaminergic drugs were applied for 15 min. Cellular cAMP was measured by cAMP Biotrak EIA system (Amersham Bioscience, Piscataway, N.J., USA) according to the manufacturer's protocol. The optical density of each well was measured using VICTOR V (PerkinElmer, Boston, Mass., USA) at 450 nm.
Immunoblot Analysis
Protein extracts were prepared from cultured cells grown at 37 ° C as described above. Cells were lysed with buffer containing 2% SDS and 62.5 m M Tris-HCl (pH 6.8). The total cell lysates were sonicated and denatured. Protein concentration was measured by using BCA protein assay kit (PIERCE, Rockford, Ill., USA). Total protein extract (10-20 g) was resolved on SDS-PAGE and transferred to nitrocellulose membranes (BioRad, Hercules, Calif., USA). The blots were incubated in buffer containing 5% skim milk in TBS-T (50 m M Tris-HCl, 150 m M NaCl, pH 7.4, 0.05% Tween 20). The blots were incubated overnight at 4 ° C with primary antibodies: phospho-CREB (1: 1,000), CREB (1: 1,000) (both from Upsate, Charlottesville, Virgin Islands, USA), CNPase (1: 200; Chemicon, Temecula, Calif., USA), glial fi brillary acidic protein (GFAP; 1: 300), and actin (1: 1,000) (both from Sigma) in TBS containing 1.5% BSA. Then the blots were incubated with horseradish peroxidase-conjugated donkey antimouse (1: 2,000), or antirabbit (1: 2,000) (both from Amersham Bioscience) in TBS containing 1.5% BSA. Immunoreactivity was detected using SuperSignal West Pico Chemiluminescent Substrate (PIERCE), and exposed to autoradiographic fi lm (Eastman Kodak, Rochester, N.Y., USA). Optical density of the bands on the fi lm was measured using a computerized image analysis system (MCID Elite, GE Healthcare, Wisc., USA).
Immunocytochemistry
Cultured cells, grown at 37 ° C as described above, were washed with PBS and fi xed with 4% formaldehyde in 0.1 M phosphate buffer, pH 7.2, then washed with PBS three times. Cells were incubated with blocking buffer containing 10% donkey serum and 0.1% Triton X-100 in PBS. For BrdU staining, cells were treated with 2 N HCl for 1 h and washed again with PBS before blocking in 10% donkey serum and 0.5% Tween 20 in PBS. Cells were incubated with primary antibodies: ␤ III-tubulin (1: 500; Covance, Berkeley, Calif., USA), BrdU (1: 75; BD Biosciences). Immunoreactivity was detected using Alexa 568-conjugated donkey antimouse antibody (Invitrogen). Cell nuclei were stained with 1 g/ml Hoechst 33342 (Invitrogen) in PBS. Images were acquired on a Nikon ECLIPSE E400 microscope (Nikon, Melville, N.Y., USA) fi tted with FITC, RITC and UV fl uorescence attachments. Images were captured using an RT Slider CCD camera and SPOT RT software (Diagnostic Instruments, Sterling Heights, Mich., USA). [Trettel et al., 2000] , was transfected with EGFP reporter or mouse D1R-EGFP construct to generate EGFP and D1R-EGFP cell lines, respectively. b PCR analysis of the three cell lines shows robust D1R and D1R-EGFP mRNA expression in the D1R-EGFP line, EGFP mRNA expression in the EGFP and D1R-EGFP lines and D2R mRNA expression in all three lines. Actin mRNA levels show equal sample loading in each lane. c When the PCR cycle number was increased to 41 to detect low abundance transcripts, low levels of D1R mRNA could be detected in the ST Hdh + / Hdh + line compared to robust expression of this mRNA in the D1R-EGFP line. d Immunocytochemical localization of D1R and expression of EGFP fl uorescence show considerable overlap between the two in cells from the D1R-EGFP line indicating that the D1R-EGFP fusion protein is expressed in the same subcellular compartments as the endogenous D1R protein. Scale bar = counted. Cell counts were expressed as ratios of BrdU-or ␤ III-tubulin-labeled cells to Hoechst 33342-labeled cells. We counted cells in 2-3 fi elds from each of 10 cultures per treatment group. Statistical signifi cance of the overall differences among the experimental groups was analyzed by one-way analysis of variance (ANOVA) and if signifi cant differences were found then to determine more specifi cally the source of the signifi cant differences, we compared the mean values between each pair of groups using Tukey's multiple comparisons test (GraphPad Software Inc., San Diego, Calif., USA).
Results
Dopamine Receptor mRNA and Protein Expression
Our initial studies examined the expression of D1R and D2R mRNA in the ST Hdh + / Hdh + line by RT-PCR. We found that this line expressed D2R mRNA ( fi g. 1 b) and very low levels of D1R mRNA that was detectable only when the PCR cycle number was increased to 41 ( fi g. 1 c). Like the ST Hdh + / Hdh + line, our EGFP line expressed D2R mRNA. Our D1R-EGFP line, which was stably transfected with mouse D1R-EGFP transgene, expressed both D2R and D1R mRNAs as well as mRNA for the D1R-EGFP fusion sequence. Thus, the ST Hdh + / Hdh + and EGFP lines expressed mainly D2R mRNA while the D1R-EGFP line expressed both D1R and D2R mRNAs. The EGFP and D1R-EGFP lines expressed EGFP mRNA as well ( fi g. 1 b). Cells from the D1R-EGFP line showed punctate EGFP labeling ( fi g. 1 d), presumably indicating the distribution of the D1R-EGFP fusion protein, in keeping with the expected intracellular distribution of D1R in neuroepithelial cells [Zhang and Lidow, 2002] . Immunostaining of D1R in the D1R-EGFP cells showed considerable overlap between D1R immunoreactivity and the EGFP signal ( fi g. 1 d) confi rming that the D1R-EGFP line overexpressed the D1R protein and that the distribution of EGFP fl uorescence overlapped with that of the D1R protein.
D1R and D2R Function
We examined whether D1R and D2R are functional in our cell lines by using cAMP accumulation assays ( fi g. 2 a-f). D1R is coupled to Gs proteins, which activate adenylate cyclase, which in turn converts ATP to cAMP [Monsma et al., 1990; Schinelli et al., 1994; Robinson and Caron, 1996] . Therefore, D1R activation increases intracellular cAMP levels, which can be measured directly using cAMP Biotrak EIA system. On the other hand, D2R is coupled to Gi proteins, which inhibit adenylate cyclase and decrease intracellular cAMP levels [Monsma et al., 1990; Schinelli et al., 1994; Robinson and Caron, 1996] . Therefore, an indirect method to assay D2R-induced suppression of adenylate cyclase and cAMP synthesis was used. In this method, we initially exposed the cells to forskolin, a direct activator of adenylate cyclase, to induce intracellular cAMP synthesis. In a parallel set of experiments, we exposed the cells to forskolin plus quinpirole, a selective D2R agonist. If the cells expressed functional D2R, then activation of these receptors by quinpirole would suppress the forskolin-induced cAMP synthesis.
In the experiments to assay D1R function, we exposed all three cell lines to dopamine or the D1R agonist SKF81297 (1 or 10 M ) for 15 min and measured cAMP accumulation. We found that cAMP levels increased only in the D1R-EGFP line, indicating that the D1R-EGFP line expressed functional D1R. We did not see increases in the cAMP levels in the ST Hdh + / Hdh + or EGFP lines at the concentrations of dopamine or SKF81297 used in this assay ( fi g. 2 a, b), presumably because of the low level of expression of D1R in these two lines ( fi g. 1 b). Therefore, the cAMP data are consistent with the D1R mRNA expression profi les for all three cell lines ( fi g. 1 b). To further assess the specifi city of D1R, we exposed the cells to the D1R antagonist Schering 23390 (10 or 20 M ) for 30 min and then to the D1R agonist SKF81297 (1 M ).
In these experiments, we did not see an increase in cAMP levels, not even in the D1R-EGFP line, which is confi rmation that the transgene-induced D1R was not only functional but also specifi c ( fi g. 2 c).
We examined D2R function by using a combination of forskolin and the D2R agonist, quinpirole. . Both dopamine and SKF81297 increased cAMP levels in the D1R-EGFP line in a dose-dependent manner ( c ), in comparison to the cAMP level under control conditions (i.e. no drugs). When D1R activity was blocked by the specifi c D1R antagonist Schering 23390 (SCH23390), prior to exposing the cell lines to the D1R agonist SKF81297, the increase in cAMP levels produced by SKF81297 alone in the D1R-EGFP line was blocked confi rming the specifi city of the D1R induced by the D1R-EGFP transgene. We examined the function of D2R by analyzing decreases in forskolin-induced cAMP levels following activation of D2R ( d-f ), because D2R activation decreases intracellular cAMP levels. Cells were exposed to forskolin 
f). These data suggest that D2R is functional in ST Hdh
+ / Hdh
+ and EGFP lines, consistent with D2R mRNA expression profi les of these two lines. However, although the D1R-EGFP line expressed D2R mRNA ( fi g. 1 b), the cAMP assays did not confi rm D2R function in this line. As mentioned earlier, a higher dose of quinpirole and a more detailed analysis of forskolin-induced cAMP levels in this cell line would be required to further characterize the D2R responses in this cell line.
Next, we examined the intracellular signaling cascade induced by the activation of D1R. Activation of the D1R stimulates adenylate cyclase, increases intracellular cAMP levels and results in phosphorylation of CREB. We found that activation of D1R by SKF81297 (1 M ) resulted in CREB phosphorylation in the D1R-EGFP line ( fi g. 2 g). D1R activation induced considerably lower levels of CREB phosphorylation in the ST Hdh + / Hdh + or EGFP lines compared to the D1R-EGFP line ( fi g. 2 g), consistent with low levels of D1R mRNA expression ( fi g. 1 b) and lack of D1R agonist-induced cAMP synthesis ( fi g. 2 a) in the ST Hdh + / Hdh + or EGFP lines.
Cell Proliferation
We examined the effects of D1R and D2R activation on BrdU incorporation in our cell lines. Since ST Hdh and EGFP lines ( d , e ), confi rming that D2R was functional in these two cell lines. Quinpirole did not decrease cAMP levels induced by forskolin in the D1R-EGFP line ( f ), suggesting that D2R was not functional or that its function in this line could not be ascertained by the assay. Phosphorylation of CREB following activation of D1R by its agonist SKF81297 was assayed by Western blot ( g ). Phospho-CREB (P-CREB) expression was robust in the D1R-EGFP line and low in the ST Hdh + / Hdh + and EGFP lines. CREB (unphosphorylated) expression did not show signifi cant changes. Actin levels indicate equal loading of samples in the different lanes.
Hdh
+ and EGFP lines showed similar receptor mRNA expression and functional profi les, we used the EGFP line as control (instead of using both ST Hdh + / Hdh + and EGFP lines as controls). We exposed the D1R-EGFP and EGFP lines to the D1R agonist SKF81297 (1 M ) or the D2R agonist quinpirole (10 M ) for 3 or 7 days and to BrdU for 1 h prior to fi xation. The concentrations of SKF81297 and quinpirole used here produced significant changes in the cAMP assays earlier. On the other hand, we found signifi cant differences in the BrdU labeling index in the EGFP line at 3 days ( fi g. 3 c; ANOVA; p ! 0.05). Tukey's multiple comparisons test indicated that the difference was due to a signifi cant decrease in the BrdU labeling index in the quinpirole-treated group compared to the SKF81297-treated group (p ! 0.05). Following exposure to the receptor agonists for 7 days, there was a signifi cant difference in the BrdU labeling index in the D1R-EGFP line ( fi g. 3 d; ANOVA, p ! 0.05) but not in the EGFP line. The difference in the D1R-EGFP line was due to a signifi cant decrease in the BrdU labeling index following exposure to SKF81297 compared to exposure to quinpirole or the control condition (Tukey's multiple comparisons test, p ! 0.05). We also found that the BrdU labeling index was signifi cantly higher in the D1R-EGFP line compared to the EGFP line at 7 days even without exposure to the dopaminergic drugs ( fi g. 3 d). Effects of D1R or D2R activation on glial cell differentiation was analyzed in EGFP and D1R-EGFP lines. The cells were exposed to the D1R agonist SKF81297 or D2R agonist quinpirole for 7 days and the expression levels of oligodendrocyte marker CNPase or astrocytic marker GFAP were analyzed by Western blot ( a ). We did not see GFAP expression under any of the experimental conditions. Lysate from adult mouse brain was used as positive control for GFAP. Although CNPase was expressed in all the experimental conditions analyzed here, its expression level quantifi ed by optical density (OD) values (ratio of CNPase to total protein, indicated by actin expression) did not show signifi cant differences among the different experimental groups ( b ).
agonists ( fi g. 4 c; ANOVA, p ! 0.05). The difference was due to an increase in the proportion of ␤ III-tubulin-labeled cells following exposure to SKF81297 ( fi g. 4 c; Tukey's multiple comparisons test, p ! 0.05).
Next, we examined if dopamine receptor activation promotes glial cell differentiation by analyzing the expression of the oligodendrocyte marker CNPase and the astrocytic marker GFAP by Western blot. We found that CNPase expression level was not altered by activation of D1R or D2R in either the EGFP or the D1R-EGFP line ( fi g. 5 a). We did not fi nd GFAP expression in any of the cell lines under any of the culture conditions ( fi g. 5 b), indicating that the cells did not differentiate into astrocytes.
Discussion
We analyzed dopamine receptor expression and function in three striatal progenitor cell lines and examined the effects of dopamine receptor activation on cell proliferation and differentiation in these cell lines. The ST Hdh + / Hdh + line, created from E14 mouse striatum [Trettel et al., 2000] , expresses functional D2R, whereas the D1R-EGFP line, created for the present study by modifying the ST Hdh It is intriguing that although D2R mRNA is expressed at high levels in the D1R-EGFP line, D2R does not appear to be functional based on the outcome of the cAMP accumulation assays. A number of explanations exist for the loss of D2R function in the D1R-EGFP cell line such as artifact of transfection with the D1R construct, expression of functional D1R, or D 1 -D 2 heterodimer formation with loss of D2R function [So et al., 2005] , or internalization of D2R. We are unable to distinguish among these possibilities at the present time. It is also possible that the D2R is functional in this line and that a higher concentration of the D2R agonist quinpirole than that used in the cAMP assays (i.e. higher than 20 M ) is necessary to activate D2R. We were unable to verify this possibility in the present study. One aim of the present study was to determine if the effects of activation of D1R and D2R on proliferation and differentiation of the cell lines were similar to the effects in striatal precursor cells in embryonic mice in vivo and in primary neuronal cultures derived from the embryonic mouse striatum in vitro [Ohtani et al., 2003; Popolo et al., 2004] . In the present study, we found that activation of D1R decreased the BrdU labeling index following 7 days in culture, suggesting that D1R activation decreased cell proliferation. These fi ndings are in agreement with the effects of D1R activation in the lateral ganglionic eminence, embryonic source of striatal neurons, and the neuroepithelium of the cerebral cortex in vivo [Ohtani et al., 2003; Popolo et al., 2004] as well as in primary cultures of cells derived from the embryonic striatum and neocortex in vitro [Zhang and Lidow, 2002; Popolo et al., 2004; Zhang et al., 2005] . Activation of D2R decreased the BrdU labeling index in the EGFP line in the present study. This effect is opposite to the effect produced by D2R activation in the lateral ganglionic eminence in vivo and in primary cultures of cells derived from the embryonic mouse striatum in vitro [Ohtani et al., 2003; Popolo et al., 2004] . The present data do not clarify the reasons for the differences. One possibility is that D2R expression without concomitant D1R expression, which is the case in the EGFP line, leads to a different effect of D2R activation on cell proliferation compared to the effects when D2R and D1R expression are concomitant, as is likely to be the case in the cells of the lateral ganglionic eminence [Ohtani et al., 2003 ]. This interpretation suggests that the cell lines used here may have unveiled interesting interactions between D1R and D2R with respect to mediation of the effects of dopamine on cell proliferation. That is, the two receptors may infl uence each other's actions such that different effects are produced when a cell expresses both receptors vis-à-vis only one receptor [So et al., 2005] . Therefore, the cell lines may be especially valuable, as the D1R-EGFP, EGFP and ST Hdh + / Hdh + lines may uniquely represent precursor cells in different parts of the embryonic CNS that may have unique dopamine receptor expression patterns (i.e. D2R only, D1R only). As mentioned earlier, whether neuroepithelial cells in some regions of the intact brain express only D1R or only D2R is unknown because it is diffi cult to ascertain dopamine receptor expression/activity patterns at the single cell level in vivo. However, in the case of postmitotic neurons of the striatum, recent reports show that striatal medium spiny neurons express both D1R and D2R [Aizman et al., 2000] , although it is possible that striato-nigral projection neurons display a predominantly D1R response and striato-pallidal neurons a predominantly D2R response [Surmeier et al., 1996] .
Our data on the effects of D1R and D2R activation on differentiation of the cells indicate that activation of D1R leads to an increase in the relative numbers of ␤ III-tubulin-positive presumptive neurons. Activation of D2R under the same conditions did not alter the proportion of ␤ III-tubulin-positive cells. These data are in agreement with earlier data, which showed that D1R activation led to an increase in the relative proportion of NeuN-positive cells in primary cultures of embryonic mouse striatal cells [Popolo et al., 2004] or an increase in neuronal cells identifi ed by morphological features in cultures from E17 rat striatum [Schmidt et al., 1996] . Moreover, in these earlier studies, D2R activation did not produce signifi cant effects of neuronal numbers.
We found that activation of D1R or D2R did not alter the expression of CNPase, an enzyme associated with myelin ensheathment of axons and virtually exclusively expressed in oligodendrocytes and Schwann cells. Our attempts to count the number of CNPase-positive cells by immunohistochemistry did not succeed due to high background staining. Therefore, we are unable to correlate the Western blot data on CNPase expression with cell counts. We found that the cell lines did not differentiate into GFAP-positive astrocytes under any of the conditions. This is in agreement with fi ndings from the ST14A line, an immortalized striatal progenitor line derived from embryonic rats [Cattaneo and Conti, 1998; Ehrlich et al., 2001] . Thus, the cell lines used in the present study appear to differentiate into presumptive neurons and oligodendrocytes, not astrocytes, and a larger proportion of the cells express ␤ III-tubulin following activation of D1R.
In summary, we report characterization of dopamine receptor expression and activity profi les of three striatal progenitor cells lines, which may serve as useful models to study the effects of dopamine receptor activation on neuroepithelial cell proliferation and differentiation. Although other cell lines of striatal origin are available [Wainwright et al., 1995; Cattaneo and Conti, 1998 ], advantages of the cell lines described here are that the lines are of mouse origin, we have characterized the prolifera-tive response of these cell lines to dopamine receptor activation and fi nally that the ST Hdh + / Hdh + line expresses functional D2R only whereas the D1R-EGFP line expresses functional D1R. However, our data do not conclusively establish the cellular mechanism that may have resulted in the loss of D2R function in the D1R-EGFP line. Nonetheless, the cell lines can serve as experimental tools to characterize the role of D1R and D2R in neuroepithelial precursor cell biology.
